Peter Schiemann

Peter Schiemann, PhD, MBA, is an expert in R&D Strategy, Clinical Development, Risk Management, Quality Management and Project Management. He is Managing Partner at Widler & Schiemann Ltd, a consulting firm focusing on all aspects of clinical development from Protocol Quality by Design to Study set-up, Project Management and Risk-based oversight of Clinical Trials such as Risk-based Monitoring. Before founding Widler & Schiemann Ltd., he worked at Roche in several functions, at PricewaterhouseCoopers in R&D Strategy Consulting and in Academic Research (Endocrinology). Dr. Schiemann is member of DIA (Drug Information Association) and RQA (The Research Quality Association).

Courses Taught